Vivos Inc (RDGL)

[SC8]

And your point? The technical differences between these two competitive Y90 injectable gels are irrelevant at this point.

YntraDose has a three year head start in clinical trials and those trials are expanding. RDGL's Radiogel is dead in the water. That's the reality. It is what it is.

Just hard to see RDGL catching up at this point. So gotta assume RDGL is headed sub penny